The candidate made by Novavax Inc. is the fifth to reach final-stage testing in the U.S. Some 30,000 volunteers are needed to prove if this vaccine — a different kind than its Pfizer and Moderna competitors — really works and is safe.



from Section Page News - Modern Healthcare https://ift.tt/3hqESR2
via IFTTT